Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laryngeal Masks | 10 | 2008 | 35 | 1.620 |
Why?
|
| Glottis | 2 | 2005 | 15 | 0.440 |
Why?
|
| Genetic Techniques | 1 | 2011 | 40 | 0.370 |
Why?
|
| Molecular Biology | 1 | 2011 | 67 | 0.350 |
Why?
|
| Airway Obstruction | 2 | 2005 | 35 | 0.290 |
Why?
|
| Respiration, Artificial | 2 | 2004 | 294 | 0.210 |
Why?
|
| Gastric Dilatation | 1 | 2002 | 2 | 0.200 |
Why?
|
| Respiration | 1 | 2002 | 89 | 0.200 |
Why?
|
| Esophagus | 1 | 2002 | 53 | 0.200 |
Why?
|
| Fiber Optic Technology | 4 | 2006 | 27 | 0.180 |
Why?
|
| Anesthesia, Inhalation | 2 | 2008 | 15 | 0.140 |
Why?
|
| Benzenesulfonates | 1 | 2016 | 15 | 0.130 |
Why?
|
| Triazoles | 1 | 2016 | 53 | 0.130 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 125 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 316 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 483 | 0.110 |
Why?
|
| Arylsulfonates | 1 | 2012 | 1 | 0.100 |
Why?
|
| Siloxanes | 1 | 2012 | 1 | 0.100 |
Why?
|
| Benzene Derivatives | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2012 | 4 | 0.100 |
Why?
|
| Vinyl Compounds | 1 | 2012 | 6 | 0.100 |
Why?
|
| Genetic Research | 1 | 2011 | 9 | 0.090 |
Why?
|
| Protein Interaction Maps | 1 | 2011 | 33 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2011 | 58 | 0.090 |
Why?
|
| Ketones | 1 | 2010 | 6 | 0.090 |
Why?
|
| Aldehydes | 1 | 2010 | 17 | 0.090 |
Why?
|
| Plasmodium falciparum | 1 | 2011 | 132 | 0.090 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 48 | 0.090 |
Why?
|
| Malaria | 1 | 2011 | 101 | 0.090 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2011 | 134 | 0.080 |
Why?
|
| Hepacivirus | 1 | 2011 | 140 | 0.080 |
Why?
|
| RNA Interference | 1 | 2011 | 593 | 0.070 |
Why?
|
| Humans | 12 | 2016 | 59799 | 0.070 |
Why?
|
| Laryngeal Edema | 1 | 2006 | 4 | 0.070 |
Why?
|
| Neoplasms | 1 | 2016 | 1258 | 0.060 |
Why?
|
| Soaps | 1 | 2005 | 6 | 0.060 |
Why?
|
| Membranes, Artificial | 1 | 2005 | 46 | 0.060 |
Why?
|
| Sterilization | 1 | 2004 | 16 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2005 | 189 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 5147 | 0.060 |
Why?
|
| Positive-Pressure Respiration | 1 | 2002 | 49 | 0.050 |
Why?
|
| Air Pressure | 1 | 2002 | 5 | 0.050 |
Why?
|
| Patellar Ligament | 1 | 2002 | 7 | 0.050 |
Why?
|
| Larynx | 1 | 2002 | 16 | 0.050 |
Why?
|
| Inhalation | 1 | 2002 | 10 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2002 | 24 | 0.050 |
Why?
|
| Solutions | 1 | 2002 | 62 | 0.050 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 24 | 0.050 |
Why?
|
| Middle Aged | 3 | 2005 | 16397 | 0.050 |
Why?
|
| Esophagoscopy | 1 | 2002 | 28 | 0.050 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 53 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2002 | 46 | 0.050 |
Why?
|
| Orthopedic Procedures | 1 | 2002 | 44 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2002 | 486 | 0.050 |
Why?
|
| Drainage | 1 | 2002 | 147 | 0.050 |
Why?
|
| Equipment Design | 1 | 2002 | 317 | 0.050 |
Why?
|
| Catalysis | 2 | 2012 | 154 | 0.040 |
Why?
|
| Aged | 3 | 2008 | 13461 | 0.040 |
Why?
|
| Male | 4 | 2008 | 27765 | 0.040 |
Why?
|
| Female | 4 | 2008 | 31093 | 0.040 |
Why?
|
| Adult | 3 | 2008 | 15879 | 0.040 |
Why?
|
| Aurora Kinase A | 1 | 2016 | 3 | 0.030 |
Why?
|
| Calorimetry | 1 | 2016 | 41 | 0.030 |
Why?
|
| Rad51 Recombinase | 1 | 2016 | 27 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2016 | 194 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2016 | 111 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 293 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 290 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 557 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 281 | 0.030 |
Why?
|
| Adolescent | 1 | 2005 | 5939 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 299 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 386 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2005 | 6041 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 708 | 0.030 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2012 | 9 | 0.030 |
Why?
|
| Palladium | 1 | 2012 | 6 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2012 | 83 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 1378 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2016 | 688 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 761 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2012 | 377 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 647 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2008 | 198 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 80 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2004 | 65 | 0.010 |
Why?
|